Isoquinoline alkaloids from Hylomecon japonica and their potential anti-breast cancer activities

• DOI: 10.1016/j.phytochem.2022.113321
• Publication Date: 2022-07-31T14:03:04Z
• Authors: Zhen Cao; Shangjun Zhu; Zhaowei Xue; Fuxin Zhang; Lei Zhang; Yu Zhang; Yuting Guo; Guanqun Zhan; Xinxin Zhang; Zengjun Guo
• Keywords: 0301 basic medicine; 0303 health sciences; 03 medical and health sciences; Alkaloids; Molecular Structure; Neoplasms; Biodiversity; Isoquinolines; Plant Roots; Rhizome; Taxonomy; 3. Good health

Four pairs of undescribed enantiomeric isoquinoline alkaloids (6S/R-(N,N-diethylacetamido)yl-dihydrochelerythrine, 6R/S-acetonyl-9-hydroxy-dihydrochelerythrine, 6S/R-acroleinyl-dihydrochelerythrine, 6S/R-acetatemethyl-dihydrochelerythrine), five undescribed isoquinoline alkaloids (6,10-dimethoxydihydrochelerythrine, 6-ethoxy-ethaniminyl-dihydrochelandine, 9-hydroxy-dihydrochelerythrine, 9-methoxy-10-hydroxy-norchelerythrine, chelidoniumine A), together with 13 known isoquinoline alkaloids were isolated from an extract of the roots and rhizomes of Hylomecon japonica. The structures of the undescribed compounds were identified by NMR, HRESIMS, UV, IR, and their absolute configurations were defined via electronic circular dichroism data and optical rotation. All of the isolated compounds were tested for their anti-breast cancer activities in MCF-7 cells. Among them, the undescribed alkaloids 6S/R-acroleinyl-dihydrochelerythrine, 6,10-dimethoxydihydrochelerythrine, 6-ethoxy-ethaniminyl-dihydrochelandine, 9-methoxy-10-hydroxy-norchelerythrine and other known alkaloids 6-methoxydihydrosanguinarine, 6-acetaldehyde-dihyrochelerythrine, dihydrosanguinaline and 10-methoxy boconoline had good inhibitory effects on MCF-7 cells of breast cancer with an IC50 lower than 20 μM.